Inhaled Nitric Oxide Delivery Systems Market: Current Analysis and Forecast (2021-2027)
$3999 – $7577
Emphasis on Type (Paediatrics, Adults); Application (Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure, Chronic Obstructive Pulmonary Disease, and Others); Product Type (Disposables, Systems); End-Users (Hospital, Ambulatory Centers, Clinics); Region and Country
Global Inhaled Nitric Oxide Delivery Systems Market is anticipated to grow with an elevated CAGR of around 6% over the forecast period (2021-2027). Inhaled Nitric Oxide is a minimally invasive therapy that is used for the treatment of conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension. It is a selective pulmonary Vaso-dilator, which reduces pressures in the pulmonary artery and improves arterial oxygenation in infants and adults with respiratory failures.
The growing adoption of inhaled nitric oxide delivery systems can be attributed to the rising prevalence of various respiratory diseases. Some of the most common respiratory diseases include lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive Pulmonary Disease (COPD). Almost 3.3 million people succumb to COPD every year, as per the World Health Organization. Also, according to the American Cancer Society estimates, in the U.S., nearly 235,070 new cases of lung cancer and tumors were detected in 2018. This in turn is positively impacting the inhaled nitric oxide delivery systems market globally.
Furthermore, the inhaled nitric oxide delivery systems market is anticipated to grow on account of the growing adoption of the inhaled nitric oxide delivery systems and favorable government initiatives along with the expedited FDA approvals. For example, in January 2020, As per Vero Biotech LLC, the FDA has approved the Genosyl inhaled nitric oxide (iNO) gas delivery system. Genosyl is a tankless, portable iNO system that eliminates the need for large nitric oxide tanks. Furthermore, the advantages offered by inhaled nitric oxide and the use of iNO as an effective treatment against the SARS-CoV-2 virus are some of the other factors driving the market across the globe.
% of Patients affected by Respiratory disease in the United Kingdom, 2020
Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc., are some of the prominent players operating in the inhaled nitric oxide delivery systems market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with inhaled nitric oxide delivery systems.
Insights Presented in the Report
“Amongst Type, paediatrics segment holds the major share”
Based on type, the inhaled nitric oxide delivery systems market is bifurcated into paediatrics and adults. The paediatrics segment accounted for the largest market share in 2020 it is estimated that it will exhibit the highest CAGR during the forecast period owing to the growing prevalence of neonatal diseases and increased adoption of inhaled nitric oxide as an effective treatment for diseases including Hypoxic Respiratory Failure. Furthermore, the supportive governmental norms and favorable reimbursement scenario are also some of the prominent reasons responsible for the growth of this segment.
“Amongst Application, hypoxic respiratory failure segment holds the major share”
Based on application, the inhaled nitric oxide delivery systems market is segmented into hypoxic respiratory failure, acute hypoxemic respiratory failure, chronic obstructive pulmonary disease, and others. The hypoxic respiratory failure segment occupied the major share of the inhaled nitric oxide delivery systems market in 2020 and it is expected to grow with substantial CAGR in the upcoming years owing to the growing prevalence of HRF, cost-effectiveness, and high efficacy of the inhaled nitric oxide therapy. For instance, in the United States, the death of nearly 18 in 1000 babies is because of the HRF and the majority of them are born prematurely.
“Amongst Product Type, disposables segment holds the major share”
Based on product type, the market is divided into disposables and systems. In 2020, the disposable segment grabbed the considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to some of the factors such as a larger consumer base, lower cost of raw materials and abundant resources availability. Furthermore, the growing demand for disposables is also because of the presence of a large number of manufacturers and the growing demand for nebulizer masks in hospitals.
“Amongst End-Users, hospital segment holds the major share”
Based on end-users, the market is fragmented into hospital, ambulatory centers, and clinics. In 2020, the hospital segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The growth of this segment is attributed to the growing utilization of these products in hospitals as they have advanced and well-established healthcare infrastructure. In addition, the increasing preference of patients for hospitals-based procedures, availability of skilled healthcare professionals to track device operations, and presence of emergency department are some of the prominent factors boosting the growth of this segment.
“North America represents one of the largest markets of inhaled nitric oxide delivery systems market”
For a better understanding of the market dynamics of the inhaled nitric oxide delivery systems market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. Asia-Pacific constitutes a major market for the inhaled nitric oxide delivery systems market industry and generated revenue of USD XX Million in 2020. However, North America is expected to grow rapidly in the upcoming years.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
The global inhaled nitric oxide delivery systems market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|1.2||Objective of the Study|
|1.5||Currency Used in Report|
|1.6||Scope of the Global Inhaled Nitric Oxide Delivery Systems Study|
|2.1||Research Methodology for the Global Inhaled Nitric Oxide Delivery Systems Market|
|2.1.1||Main Objective of the Global Inhaled Nitric Oxide Delivery Systems Market|
|6||GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET REVENUE|
|8.1||Hypoxic Respiratory Failure (HRF)|
|8.2||Acute Hypoxemic Respiratory Failure (AHRF)|
|8.3||Chronic Obstructive Pulmonary Disease (COPD)|
|11.1||NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET|
|11.1.3||Rest of North America|
|11.2||EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET|
|11.2.6||Rest of Europe|
|11.3||ASIA PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET|
|11.3.5||Rest of Asia Pacific|
|11.4||REST OF THE WORLD INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET|
|13||INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET OPPORTUNITIES|
|14||INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET TRENDS & INSIGHTS|
|15||LEGAL & REGULATORY FRAMEWORK|
|16.1||Demand Side Analysis|
|16.2||Supply Side Analysis|
|16.2.1||Top Product Launches|
|16.2.2||Top Business Partnerships|
|16.2.3||Top Merger & Acquisitions|
|17||VALUE CHAIN ANALYSIS|
|18.1||Porter’s Five forces analysis|
|18.1.1||Bargaining power of Supplier|
|18.1.2||Bargaining power of Buyer|
|18.1.4||Availability of Substitute|
|18.1.5||Threat of new Entrants|
|19.1.3||Key Product/Services Offerings|
|188.8.131.52||Financial Overview of Mallinckrodt Pharmaceuticals|
|184.108.40.206||Business Expansion and Investments|
|220.127.116.11||Merger and Acquisition|
|19.6||Air Liquide Healthcare|
|19.10||Praxair Technology Inc.|
Analyzing the historical market, estimation of the current market, and forecasting the future market of the global inhaled nitric oxide delivery systems market were the three major steps undertaken to create and analyze the adoption of inhaled nitric oxide delivery systems in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global inhaled nitric oxide delivery systems market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the inhaled nitric oxide delivery systems through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the inhaled nitric oxide delivery systems market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as type, application, product type, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of inhaled nitric oxide delivery systems across the globe.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the practice management system. Further, we conducted factor analysis using dependent and independent variables such as technological advancement and the growing prevalence of respiratory diseases. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the inhaled nitric oxide delivery systems sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the inhaled nitric oxide delivery systems market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (US$) and the adoption rate of inhaled nitric oxide delivery systems across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the inhaled nitric oxide delivery systems market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the inhaled nitric oxide delivery systems market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type, applications, product type, and end-users of the inhaled nitric oxide delivery systems market.
The main objective of the Inhaled Nitric Oxide Delivery Systems Market Study
The current & future market trends of inhaled nitric oxide delivery systems were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of inhaled nitric oxide delivery systems in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type, applications, product type, and end-users
- Define and analysis of the regulatory framework for the inhaled nitric oxide delivery systems industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the inhaled nitric oxide delivery systems market for the major region
- Major regions studied in the report include North America, Europe, Asia-Pacific, and Rest of the world
- Company profiles of the inhaled nitric oxide delivery systems market and the growth strategies adopted by the market players to sustain in the fast-growing market
Deep dive regional level analysis of the industry